CONNECT WITH US
Tech

Tech

GLP-1 drugs could have a surprisingly large environmental payoff

Ars Technica - Tech logo

Published on

Add as a preferred source on Google
GLP-1 drugs could have a surprisingly large environmental payoff

GLP-1 weight-loss medicines such as Ozempic and Wegovy could affect much more than the waistlines of the people who take them. If widely used, our new research suggests these appetite-suppressing medicines could transform the global food system and free up vast areas of agricultural land.

The global food system is ultimately driven by demand. If people eat less, producers respond, affecting production, prices, trade, and how much land is needed. We used a powerful computer simulation to explore scenarios ranging from GLP-1 use concentrated in high-income countries to widespread global access.

With widespread use of these medicines among adults living with obesity, we estimate that reduced calorie intake could prevent up to 6.6 million deaths each year by 2050, while freeing up as much as 32 million hectares of agricultural land—an area slightly larger than Italy—for other uses.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.